U.S. Subpoenas Blood-Test Files In New Health Care Fraud Inquiry
In a rapidly widening effort to root out health care fraud, Federal officials have subpoenaed Medicare and Medicaid billing records of at least five of the country's largest medical laboratory companies. Although no charges have been brought against the companies, the investigation of the $32-billion-a-year blood-testing industry is the latest of several inquiries by law-enforcement agencies. Federal officials have said that medical fraud may account for $80 billion to $100 billion of the more than $900 billion that Americans will spend on health care this year. Companies Confirm Subpoenas Corning Inc., which has the nation's largest blood-testing business, confirmed yesterday that both its Metpath subsidiary and Damon Clinical Laboratories, which it acquired last month, had received subpoenas from the office of the Inspector General of the Department of Health and Human Services. SmithKline Beecham, the second-largest laboratory company, also confirmed that a subpoena had been received.
